Scholars@Duke
Katherine Zhou

Overview

Fellowship: Duke Hematology–Oncology (2022-present)
Residency: Duke Internal Medicine (2020-2022)

Medical/Graduate: The University of Chicago (2012-2020)
Doctor of Philosophy in Biochemistry and Molecular Biophysics, June 2018.
Doctor of Medicine, June 2020.

Undergraduate: Yale University (2008-2012)
Bachelor of Sciences in Molecular Biophysics & Biochemistry, May 2012.

Current Appointments & Affiliations

Recent Publications

Comprehensive Genomic Profiling in Non-Myeloid Hematologic Malignancies Identifies Variants That Can Alter Clinical Practice.

Journal Article Hematol Rep · September 30, 2024 BACKGROUND: Comprehensive genomic profiling (CGP) is frequently adopted to direct the clinical care of myeloid neoplasms and solid tumors, but its utility in the care of lymphoid and histiocytic cancers is less well defined. METHODS: In this study, we aime ... Full text Link to item Cite

Targeting Claudin-18.2 for cancer therapy: updates from 2024 ASCO annual meeting.

Journal Article J Hematol Oncol · August 26, 2024 Multiple classes of therapies targeting claudin-18 isoform 2 (CLDN18.2) are under development for the treatment of advanced gastroesophageal adenocarcinoma and other solid tumors. At the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting, the ... Full text Link to item Cite

Breast cancer exploits neural signaling pathways for bone-to-meninges metastasis.

Journal Article Science · June 21, 2024 The molecular mechanisms that regulate breast cancer cell (BCC) metastasis and proliferation within the leptomeninges (LM) are poorly understood, which limits the development of effective therapies. In this work, we show that BCCs in mice can invade the LM ... Full text Link to item Cite
View All Publications

Recent Grants

Clinical and Therapeutic Implications of the Small Nucleolar RNA Snord67 in Breast Cancer Lymphatic Metastasis

ResearchPrincipal Investigator · Awarded by American Society of Clinical Oncology · 2024 - 2025

View All Grants